Author: Derek Bagley

Share

Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:...
Share

Shouldering Responsibility: Could a Male Contraceptive Gel Be a Birth Control Game Changer?

When a presentation at ENDO 2024 highlighted a male contraceptive gel that suppresses sperm production faster than other hormone-focused methods of male birth control, the Boston Convention Center was abuzz. Containing segesterone acetate and testosterone and applied to both shoulders, this groundbreaking new birth control could prove revolutionary. When the results from an ongoing multicenter...
Share

Pharma Fridays — October 11, 2024

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Boehringer Receives U.S. FDA Breakthrough Therapy Designation and Initiates Two phase III Trials in MASH for Survodutide On October 8, Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI 456906), a...
Share

Texas Nexus: A Multidisciplinary Healthcare Team Finds a Lifesaving Link Between Research and Clinical Practice

Shumei Meng Shumei Meng, MD, PhD, from the Baylor University Medical Center and the Texas A&M School of Medicine, discusses a remarkable case study from JCEM Case Reports detailing how endocrinologists may have discovered a new syndromic association that may have saved a pregnant patient’s life. Sometimes in medicine, everything aligns, and patients with unusual presentations who...